Trial · NCT02504372
Adverse events456
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 456
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hyperthyroidism | Endocrine disorders | Pembrolizumab | 62 | 580 | 65 |
| other | Hyperthyroidism | Endocrine disorders | Placebo | 17 | 581 | 18 |
| other | Hypothyroidism | Endocrine disorders | Pembrolizumab | 120 | 580 | 148 |
| other | Hypothyroidism | Endocrine disorders | Placebo | 27 | 581 | 29 |
| other | Constipation | Gastrointestinal disorders | Pembrolizumab | 35 | 580 | 38 |
| other | Constipation | Gastrointestinal disorders | Placebo | 41 | 581 | 53 |
| other | Diarrhoea | Gastrointestinal disorders | Pembrolizumab | 104 | 580 | 179 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 82 | 581 | 160 |
| other | Nausea | Gastrointestinal disorders | Pembrolizumab | 52 | 580 | 64 |
| other | Nausea | Gastrointestinal disorders | Placebo | 37 | 581 | 48 |
| other | Asthenia | General disorders | Pembrolizumab | 44 | 580 | 66 |
| other | Asthenia | General disorders | Placebo | 32 | 581 | 39 |
| other | Fatigue | General disorders | Pembrolizumab | 96 | 580 | 131 |
| other | Fatigue | General disorders | Placebo | 89 | 581 | 118 |
| other | Influenza like illness | General disorders | Pembrolizumab | 34 | 580 | 39 |
| other | Influenza like illness | General disorders | Placebo | 32 | 581 | 36 |
| other | Pyrexia | General disorders | Pembrolizumab | 31 | 580 | 34 |
| other | Pyrexia | General disorders | Placebo | 32 | 581 | 48 |
| other | Nasopharyngitis | Infections and infestations | Pembrolizumab | 50 | 580 | 65 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 32 | 581 | 44 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02504372/events